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 Marcia Angell, Editor-in-Chief of the New England Journal of Medicine, once 
said, “…our health care system creates ethical dilemmas that no health care system 
should create” (Angell).  One of these ethical dilemmas is the lack of insurance coverage 
for hearing assistance devices and surgeries, which add to the quality of a person’s life. 
Hearing is one of the five major senses, but millions of Americans are hearing impaired 
throughout the U.S. The largest populations in the United States affected by hearing loss 
are the elderly and the aging generation of baby boomers. In fact, 25% of adults over age 
65 experience disabling hearing loss (Quick Statistics). Recent studies demonstrate that, 
“Severity of hearing loss is associated with reduced quality of life in older adults” 
(Dalton).  Another study, the Blue Mountain Hearing Study, also identified the “disease 
burden of age-related hearing impairment on health-related quality of life in a population-
based cohort of older persons” (Chia). The lack of coverage for services to aid in the 
restoration or partial-restoration of hearing should be considered a gross inequity in the 
world’s most medically advanced country. 
The elderly may often take center stage on this issue but the effects of hearing 
loss are widespread and can be found in all age groups and socio-economic classes. 
According to the U.S. Department of Health and Human Services, “About 2 to 3 out of 
every 1,000 children in the United States are born with a detectable level of hearing loss 
in one or both ears” (Quick Statistics). In addition, 90% of children born with hearing 
loss are born to hearing parents who do not understand their child’s condition fully 
because they have not experienced it themselves. One in eight Americans twelve years of 
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age or older suffer from hearing loss in one or both ears. This statistic constitutes 13% of 
the population of the U.S. or 30 million Americans. (Quick Statistics). In addition a 
recent study by Dr. Judith E. Cho Lieu, noted among children and youth grade failure as 
well as speech impairment and delays are negative results of childhood hearing loss, 
which negatively affect social skill development, often resulting in behavioral problems 
(Cho Lieu).  
There are three types of hearing loss, which are responsible for these statistics. 
Conductive hearing loss is due to problems with the ear canal, eardrum, or the middle ear, 
which is home to many small bones. Sensorineural hearing loss is due to inner ear 
problems and nerve problems. Mixed hearing loss is a combination of the two types 
previously mentioned (Types, Causes, Treatments).  There are also various levels to each 
of these types of loss: mild, moderate, severe, or profound. Mild hearing loss means that 
the individual will have some trouble keeping up with conversations, especially in noisy 
environments. Moderate hearing loss means an individual will have trouble keeping up 
with conversations without the use of a hearing aid. Severe hearing loss sufferers greatly 
benefit from hearing aids but often rely heavily on lip reading even when they do use 
them. Many people with severe loss sign as well. Profound hearing loss means that the 
person relies almost completely on lip reading and sign language but occasionally they 
can hear very loud sounds (What are the different degrees of hearing loss?).  
 There are various treatment options for each type of hearing loss. The most 
common treatment is wearing hearing aids, which are used in cases where medicine and 
surgery are not suitable for the patient or are too expensive. Many factors such as 
listening needs, lifestyle, and individual hearing loss impact which kind of hearing aids 
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will best suit a patient.  Hundreds of different makes and models of external hearing aids 
can be found in the U.S. market today. Patients can expect to pay anywhere from $1,000 
to $8,000 for a pair of custom hearing aids, most of which are not covered by insurance. 
A single hearing aid can cost up to $600 (Hearing Aid Buying Guide). Hearing aid 
purchases reached a peak in 2008 when the binaural purchase rate increased 78.8% for all 
users. New hearing aid owners, however, decreased by 39.9% as the price of hearing aids 
rose (Kochkin). Hearing aids are the third most widely used assistive medical device in 
this country after canes and eyeglasses. Nevertheless, most Americans with hearing loss 
do not use hearing aids; “Of the estimated 23.5 million Americans with hearing loss, only 
about 3.78 to 5 million own hearing aids” (Adams 1). 
 Cochlear implants are another device that can improve the condition of people 
with severe and irreparable hearing loss. These small devices surgically implanted in the 
ear can help a person to hear and understand more speech than is possible with even the 
best external hearing aid (Hearing Loss Treatment).  Cochlear implants consist of an 
external portion, which sits behind the recipient’s ear and an internal portion, which is 
surgically implanted under the recipient’s skin. This one small device consists of a 
microphone to amplify environmental sounds, a speech processor, which arranges sounds 
picked up by the microphone, a transmitter, which converts the sounds into electrical 
impulses, and an electrode array, which collects the impulses and sends them to the 
auditory nerves. As of December 2012, about 58,000 adults and 38,000 children had 
received this type of implant in the United States. Some insurance companies may cover 
the expense of this surgery or a portion, but not always (Cochlear Implants). The average 
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cost for the entire procedure including post-operative rehabilitation often exceeds 
$40,000 (Cochlear Implant Frequently Asked Questions).  
 An examination of current standard health insurance policies on hearing problems 
illuminates the commoditization of this portion of healthcare. The treatment of hearing 
aids as market commodities means the devices are only available to those who can pay 
for them out of their own pockets. The best example from the insurance sector to use here 
is the case of Medicaid. Medicaid provides assistance for low-income individuals who 
qualify. The new terms of qualification set out by the Affordable Care Act expand 
Medicaid coverage to every American under age 65 with an income below 138% of the 
federal poverty line unless they receive insurance through another source, such as an 
employer (Ezekiel pp. 207). Both the state and federal governments jointly fund the 
program. Each state has flexibility under the broad guidelines set out for Medicaid. 
Remarkably, hearing health services are optional under the Federal guidelines for 
minimum coverage set out for Medicaid. As a result, many states do not cover adult 
hearing health services, even though a federally mandated program covers children until 
the age of 18 in all fifty states through a program known as EPSTD or Early and Periodic 
Screening, Diagnosis, and Treatment Program (Medicare Coverage of Hearing Aids).  In 
recent years coverage, specifically for cochlear implants has expanded. Medicare and the 
Veteran’s Administration offer at least partial coverage and federal law mandates that 
Medicaid cover the procedure for any child under 21 who qualifies (Cochlear Implant 
Frequently Asked Questions).  The coverage for private insurance varies greatly 
depending on each independent provider but many private health insurance companies 
consider hearing aids and cochlear implants “exclusions,” which a term insurance 
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companies use for the conditions and treatments that are not covered by a policy 
(Hoffman 98). 
The health care system in the U.S. suffers from perverse incentives, that send 
contradictory messages to both the public and health care professionals. The 
commoditization of American health insurance was perpetuated by the social conditions 
created by World War II. During the war President Franklin Delano Roosevelt froze the 
wages of workers. In order to recruit and retain workers, employers turned to enhancing 
fringe benefits, such as healthcare coverage. Private insurers were already on the scene in 
the forms of both Blue Cross and Blue Shield and were very successful. During such a 
tumultuous time major reform in a system that was working perfectly fine seemed to be a 
waste of resources. In the opinion of some, America missed her chance to implement 
universal coverage during FDR’s presidency when Britain was accepting the Beveridge 
Report and using FDR’s own terminology to make it a success. Britain came out with a 
“cradle to grave” coverage system; America came out with an intricate system of 
confusion (Blumenthal & Morone pp.21-56). Many small decisions in the health care 
sector added up to produce today’s predicament where people who cannot afford 
insurance are left without and even those who can are left without coverage for certain 
medical procedures. As Beatrix Hoffman writes, since 1930 “The gap between public 
expectations and the reality of the limited coverage led to discontent…” (90).  Hearing 
loss is a widespread example of this. The ability to hear is intrinsic to being human, 
however, in the U.S. the hearing aid sector of the healthcare industry is treated mainly as 
a commodity.  Insurance companies are willing to pay for testing to determine if a person 
suffers from hearing loss, however, they will not pay for hearing aids or surgery to fix the 
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problem. Within in the framework of the world of those hard of hearing, a major problem 
within the health sector is highlighted; is healthcare really a commodity or a right in the 
United States?  
 According to the Robert Wood Johnson Foundation, “Four in five physicians say 
patients’ social needs are as important to address as their medical conditions…” (Fenton). 
Hearing loss is clearly classified as a medical condition but it seriously affects a patient’s 
social needs as well augmenting the importance of preserving each individual’s ability to 
hear. Multiple aforementioned studies have found negative social effects on both the 
elderly and the young who are afflicted with such impairments. The ability to adequately 
communicate and be communicated with is essential to the health, safety, and social well 
being of patients. Why then is something that is so basic to being human commoditized in 
the U.S. healthcare system?  The answer is American values. 
 In order to understand the mixed incentives of the current U.S. system, where 
some aspects of health are treated as rights while others are treated as commodities, one 
must understand the values that resulted in this system. The United States prides itself on 
democracy, liberty, freedom, and free markets. American skepticism of anything that can 
be labeled as socialist or has too much government involvement runs very deep. America 
was born on the principle that this country would forever be a place where freedom 
resides, as recorded by our founding fathers in the Constitution. Universal health 
coverage, which would treat healthcare as a right for all, has been given the label 
“socialized medicine” and is therefore seen as a threat to these American ideals. President 
Dwight D. Eisenhower solidified the American values of competition, free markets, and 
limited government involvement when he signed into law the employer-based health 
Whipple 7 
insurance system that is still the basis of the healthcare system in the U.S. today. 
Eisenhower acted out of necessity to soothe public upheaval during a tumultuous time for 
both foreign and domestic affairs during his presidency (Blumenthal & Morone 99-130).  
Fear of government control, however, does not mean that America completely lacks 
compassion and human sentiment. This is where the confusion begins.  
Since the U.S. system is based on private health insurance plans, one would 
assume that a person must purchase insurance, or receive it through their employer, in 
order to access medical care at all. In a market system this is usually the case, however, in 
the healthcare system it is not. Healthcare is treated as a commodity for the majority of 
Americans, but what about a person who just got into a nearly fatal car accident and has 
no insurance? The emergency medical response team is not going to leave that man to die 
in the street, insurance or not. America possesses the most advanced healthcare in the 
world and as the current world superpower it would be beyond barbaric to let citizens die 
in the street because they could not afford coverage. That person will be taken to the 
hospital and stabilized, regardless of cost to the hospital and providers. Similarly, to this 
situation, if the same uninsured person were to walk into the ER after an accident, he or 
she would be treated then as well. Written into laws, such as the Emergency Medical 
Treatment and Labor Act or EMTALA, America provides safeguards for the uninsured 
(EMTALA). The statutory provisions of EMTALA “…impose specific obligations on 
certain Medicare-participating hospitals and critical access hospitals…” and  “These 
obligations concern individuals who come to hospitals “dedicated emergency 
departments” and request examination or treatment for a medical condition and apply to 
all of these individuals regardless of whether they are beneficiaries of any program under 
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the act”(Medicare Program; EMTALA: Applicability to Hospital Inpatients and Hospitals 
With Specialized Capabilities).  
In Thomas Murray’s article, American Values and Health Care Reform he 
discusses the implications of these American values. He writes, “Stewardship requires us 
to be mindful of the basic needs of others and of the power and responsibility we have to 
use the resources in our control to meet those needs” (Murray). Hearing is one of the five 
basic senses, yet Americans are not mindful of this basic need and the cost of financing it. 
Murray believes that the work of reforming the healthcare system must be accompanied 
by a dialogue about what values should form the foundation of the system. These values 
must be understood and reinforce one another in order to be successful (Murray). The 
lesson here is a confusing one; America does not have formal universal healthcare 
coverage, but in reality an informal system, or safety net, does exist. 
Now we need to exam this issue in three different settings to underscore the 
importance of the ability to hear and the impact that the lack of coverage due to the 
commoditization of this sector of the healthcare industry has on everyday people. Let’s 
consider three cases that underscore how hearing treatments are a commodity in the U.S. 
Paul  
My father watches the television on mute. Most people take advantage of the 
volume settings on television sets, but it does not matter all that much if the 
person watching it cannot hear. His hearing loss was gradual, and deteriorated 
little by little over time. Years of farm work with heavy machinery, hunting with 
high-powered rifles, and battling sinus infections due to environmental allergies 
took their toll. When my dad watches television volume is a moot point; he reads 
lips or risk blowing the speakers completely. Hearing aids have been around for 
decades and are easily accessible in this affluent country that we reside in, so 
why didn’t my father purchase a set the moment his hearing started to fail? The 
answer is simple: money. My father has six children and, as a byproduct, more 
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financial responsibilities than most. Hearing aides, whether surgically implanted 
(cochlear implants) or external amplifiers are not covered by health insurance in 
the United States.  Like many parents, my father put the needs of his children 
before his own needs for many years until his hearing loss interfered in his day-
to-day activities. My father now owns Beltone Promise hearing aids, which cost 
him $8,000 out of pocket. As a farmer, his ability to hear is vital to his safety on 
the job while he is working with heavy machinery and communicating with labor 
teams. My father suffers from severe hearing loss in his left ear and his right ear 
suffers from moderate hearing loss.  
  As Jen Christensen notes, “Hearing loss is an ‘invisible,’ and widely uninsured problem.” If a person loses a limb, insurance usually covers the cost of a prosthetic limb; individuals with ED can obtain Viagra or other drugs through their insurance company. This generous approach to coverage for disabilities does not extend to hearing; in fact, hearing loss is not categorized as a disability. If it were, however, hearing loss would rank as the number one disability class in the country. Hearing aids, therefore, are considered an elective purchase. Only 19 states out of 50 require health plans to cover hearing aids; only 3 out of those 19 states extend coverage to adults as well as children. Even when private insurance does pay the only aspect private insurers typically cover is the hearing exams that assess the level of loss. A recent study conducted by Virginia Ramachandran who is a senior staff audiologist in the Division of Audiology of the Henry For Hospital in Detroit, MI, showed that 75% to 80% of adults with hearing loss do not invest in hearing aids. The study showed that the only group that consistently obtained hearing aids were those individuals whose insurance paid for them in full (Christensen).  
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 Coverage for prosthetic limbs is much more expansive. Just as prostheses, hearing aids and cochlear implants help to return a body to its fully functioning state as best as possible, so why then do these devices not receive equal coverage? Medicare Part B covers prosthetics limbs (Orthotics & Artificial Limbs). All 50 states have at least partial coverage for prosthetic limbs under Medicaid (Medicaid Benefits: Prosthetic and Orthotic Devices). Private insurance coverage varies though most private insurance companies cover prostheses. This coverage may be capped or have a lifetime limit (Financial Assistance for Prosthetic Services, Durable Medical Equipment, and Other Assistive Devices).   My father’s case illustrates the plight of most American adults with a hearing impairment. At 62 years old he is not yet eligible for Medicare, however, the situation would not change much even if he were because Medicare also does not cover most hearing aids. In order to exam the coverage, or lack there of, for hearing services an examination of the Medicare, Medicaid, and private insurance policies is necessary. Medicare Part B will cover diagnostic hearing tests and balance exams if ordered by a health care provider in order to determine if treatment is necessary. Medicare Part B will not cover routine hearing exams, fitting for hearing aids, or hearing aids. Even for the covered exams the patient is still responsible for their Part B deductible and 20% of the “Medicare approved amount” for the doctor’s services (Hearing and balance exams & hearing aids).  Cochlear implant coverage under Medicare is different. CMS issued a decision that “The evidence is adequate to conclude that cochlear implantation is reasonable and 
necessary for treatment of bilateral pre-or-postlinguistic, sensorineural, moderate-to-
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profound hearing loss in individuals who demonstrate limited benefit from amplification” (Decision Memo for Cochlear Implantation). However, hearing loss is so specific to each individual and the various models of cochlear implants, which the FDA has approved, made deciding how much to reimburse difficult for CMS. With regards to reimbursement CMS concluded “Although we do not find sufficient evidence to support 
across the board coverage of cochlear implantation for all persons who have hearing loss 
scores ≤ 60% correct, a sufficient inference of benefit can be drawn to support limited 
coverage in the context of a clinical trial that provides rigorous safeguards for patients” 
(Phurrough).  There is some hope for the private insurance sector to take on more coverage since the ACA lists hearing aids as a standard health benefit. Hearing aids are listed number 36 on HHS’s benchmark plan format for each state. Unfortunately, each state is only required to meet the first ten essential benefits set out by the ACA. HHS clearly seems to recognize that haring aid coverage should be considered a standard component of health insurance plans (Hearing Aids and the Affordable Care Act).  The commoditization of hearing has led to a complex and competitive market for hearing aids and other assistive devices. It is important to remember that most people purchasing hearing aids are age 65 or older. Elderly consumers are more susceptible to high-pressure sales tactics and more trusting than the average consumer.  A study conducted by Eun-Jin Kim and Loren Geistfeld shows that elderly vulnerability is a three dimensional phenomenon encompassing their health status, cognitive ability, and social network, which all tend to degenerate with age (Geistfeld & Kim). Door-to-door hearing aid dispensers take full advantage of this 
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susceptibility and augment it by making sales within people’s homes. The manufacturing, sale, and distribution of hearing aids if regulated by three bodies of law that overlap: federal laws, state laws, and state licensing boards. Federal regulations state that hearing dispensers are not permitted to sell hearing aids to an individual who has not produced a statement signed by a licensed physician stating that the patient has been medically evaluated and is a candidate for hearing aids. Individuals can sign a waiver of the medical examination as long as the dispenser notifies the client that the evaluation is in their best interest medically (Adams).  Signing this medical waiver can be extremely dangerous as Dr. Dennis Colucci, a forensic audiologist from a private practice in Laguna Hills, CA, explains, “Ill-fitted 
hearing aids come in all sizes and circuits from people who manufacture devices or are 
licensed to fit and sell them. Blurry hearing aids not only worsen patients' social isolation 
and deprivation, but they also result in public confusion and distrust.”  Licensing boards differ from state to state but they all serve the same basic purpose, which is to “set standards for minimum competency, licensure, and practice; investigate complaints; and discipline practitioners” (Adams). These boards 
lack funding to be proactive and, therefore, often act retroactively when a complaint has 
been filed. State to state differences for licensing hearing aid dealers make the system 
complicated but and individual who fits the minimal requirement is generally someone 
with a high school diploma or GED who is 18 years of age or older (Adams). 
 False or misleading advertisement is a huge impediment to the effective use of 
hearing aids within the U.S. Dispensers abuse the regulations under which consumers can 
waive their medical evaluation and misrepresent the benefits received from using hearing 
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aids. In April of 1993 the FDA warned six manufacturers about misrepresenting the 
capabilities of hearing aids (i.e. such as claiming that hearing aids could eliminate 
background noise). Beltone, the company my father purchased his hearing aids from, was 
one of the six companies cited by the FDA. In 1976 these six companies were also issued 
consent orders against them by the Federal Trade Commission, which instructed them to 
cease making “unreasonable” claims about their products’ abilities. Waiving one’s 
medical examination may lead to the purchase of an ineffective or inappropriate model 
for their type of hearing impairment (Adams). 
 Quality of life is at stake for my father and millions of other Americans who 
suffer from hearing loss. Like my father, many hearing loss sufferers, especially the 
elderly, take shame in undergoing the process for and making the purchase of assistive 
devices. In 2010 -2011 the Ida Institute held a series of seminars on the theme Living 
Well With Hearing Loss with their distinguished faculty Leslie Jones, PhD, Patricia 
McCarthy, PhD, Christopher Lind, PhD, and Jean-Pierre Gagné, PhD. During the 
seminar, the faculty highlighted the importance of recognition and acceptance of hearing 
impairment. Once acceptance is achieved then audiological rehabilitation goals can begin 
to be reached (Living Well With Hearing Loss). My father has financial concerns about 
his hearing aids but admitting that he needed them was just as hard as handing over 
$8,000. My father could easily recognize he had a problem but accepting that problem 
and allowing others to see a physical sign that he is hard of hearing took about two years 
for him to cope with. 
Janet  
My Aunt Janet, suffers from hearing loss of a different nature. Janet is a breast 
cancer survivor who had a double mastectomy about 15 years ago and then 
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survived lung cancer about 8 years ago by undergoing chemotherapy as well as 
the partial removal of her left lung. The months of rigorous chemotherapy not 
only caused my aunt to lose her hair and copious amounts of weight, but it also 
caused her to lose much of her hearing. The University of Arizona Cancer 
Centers notes, “Hearing loss has become one of modern cancer therapy’s most 
prevalent side effects. In fact, hearing loss is among the most underreported, yet 
potentially devastating, side effects endured by many chemotherapy patients” 
(Prevenas). Patients often do not think about the fact that they could lose their 
hearing from cancer treatment, nor do most of them care during such a pivotal 
time. Patients also rarely recognize that they are losing their hearing until it is too 
late for treatment because the loss first impacts higher frequencies, which are far 
above the range of normal speech recognition (Prevenas). Janet is an 
elementary level special needs teacher; the ability to hear is essential to her 
profession. Should hearing aids not be covered as part of her full cancer 
treatment since they would be a direct result of it?  
 
 Cancer treatment is very costly investment and the amount that patients will pay 
out-of-pocket depends on their insurance plan, if they have any at all. Both public and 
private insurance cover at least a portion of treatment costs and the uninsured can usually 
gain assistance from public and private programs, such as the TANF program 
(Temporary Assistance for Needy Families). The potential financial burden that comes 
with a cancer diagnosis seems insignificant in the face of death. Although, cancer 
treatments have made huge strides and more people are surviving various types of cancer 
than ever before, there is a lurking threat of losing one’s hearing due to life saving 
treatment and reducing the quality of the life they are trying so desperately to save. The 
likelihood of a patient rejecting chemotherapy or radiology based on the risk of hearing 
loss is so minimal that this problem has essentially been swept under the rug.  
 How do chemotherapy and radiation contribute to hearing loss? As Dr. Paul 
Gidley explained, toxicities from chemotherapy treatment cause nerve damage, which 
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results in the loss of hearing, or ototoxicity. Gidley's subspecialty is otology and 
neurotology, which means he specializes in the care of chronic ear disease (Q&A: Cancer 
and Hearing Loss). This type of hearing loss is sensorineural and is most often 
permanent. High doses of radiation near the ear or to the brain can cause inflammation 
and subsequent wax build up in the outer ear, fluid build up in the inner ear, or stiffness 
within the middle ear bones or eardrum. These problems can result in conductive hearing 
loss, which may improve over time but may also be permanent (Hearing Loss, 
Vanderbilt-Ingram Cancer Center). A study on sensorineural hearing loss after 
chemotherapy and radiation was published in the Clinical Journal of Oncology and found 
that patients who received radiotherapy and chemotherapy suffered from greater 
sensorineural hearing loss than those who only received radiotherapy. High frequency 
sounds in the speech range were especially impacted. (Kein Low). 
 Prior to treatment the University of Arizona Cancer Center strongly suggests that 
patients undergo a baseline audiogram that focuses on high frequencies, Distortion 
Product Otoacousitc Emissions (to test inner ear cell hair function), and 
videonystagmography (to evaluate balance function). Patients should have follow up tests 
done at pre-determined intervals by an audiologist and should also make contact with 
neurotologist or inner specialist in case hearing is impacted throughout treatment 
(Chemotherapy-Induced Hearing Loss). The two main detriments to cancer patients’ 
hearing during treatment is radiation to the head or ear and chemotherapy from the 
“platinum” group like cisplatin or carboplatin. The physical effects of this hearing loss 
are balance issues, which means a greater likelihood for dangerous falls. Hearing loss has 
also been linked to the development of certain forms of dementia. Psychologically 
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depression, isolation, and anxiety are all results. Economically, there is a higher rate of 
unemployment, an overall lower standard of living, and difficulty advancing in one’s 
career. Although little statistical data is currently available, a landmark study of 67 
chemotherapy patients between the ages 8-23 years old found that 61% of them 
developed hearing loss after treatment. Most of the hearing loss experienced was high-
frequency loss. These treatments that save lives depreciate that same life’s value (Klop).   
External and internal breast prostheses and post-surgical bras for breast cancer 
patients who undergo mastectomies are covered by both public and private insurance. 
Prosthetic breasts are merely an aesthetic or cosmetic surgery, which aims to restores 
how the woman’s appearance before her mastectomy. Is the purpose of hearing aids not 
to achieve the same goal? To return a person who is missing some feature to as close to 
whole and functioning properly as possibly? Once again, prosthetic coverage raises the 
question about why hearing aids and services are not covered. All women with Medicare 
are covered for these procedures. Part B covers external prosthetic, post-surgical bras, 
and breast reconstruction surgery performed in an outpatient setting. Part A covers 
surgically implanted breast prostheses after a mastectomy in an inpatient setting (Breast 
Prostheses). Private insurance coverage varies, however; generally external breast 
prostheses are covered subject to specifications. For instance, some private insurance 
companies do not cover custom breast prostheses because there is a standard model 
available, which meets the medically necessary criteria. Prosthetic replacements due to 
changes in size are usually covered by insurance as long as a prescription with reasoning 
for the replacement is provided by a doctor (Breast Prosthesis).  
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As was the case with my aunt, many women feel that procuring prostheses after 
mastectomies helps them cope with such a drastic change and permanent bodily change. 
The prostheses essentially raise the quality of the patients’ life by keeping their self-
esteem intact after such a hard fought battle. If purely cosmetic surgical and non-surgical 
coverage is extended to cancer patients as part of their care then why shouldn’t hearing 
aids and cochlear implants also be covered? There are ample studies that show the 
improved quality of life that these devices provide to their users. To give a patient a new 
lease on life only to have her faced with the great physical and financial burden of 
hearing loss is counterproductive.  
Jamison –age four- 
Jamison suffers from moderate hearing loss and underwent two surgeries to 
have tubes surgically implanted in his ears to improve his hearing. Tube 
implantation requires small tubes to be placed in the eardrums to help ventilate 
the area behind the eardrum. This equalizes pressure as well as drains fluid to 
keep the middle ear pressure closer to atmospheric pressure (Middle Ear 
Infections and Ear Tube Surgery). Jamison is a wonderful little boy, but his 
frustration over not being able to hear well manifests itself in his behavior. Before 
his second surgery to replace his original tubes, Jamison began having 
uncharacteristic and frequent tantrums. His speaking voice became more childish 
and his pronunciation less clear. Jamison may not have a profession that his 
hearing impairment can negatively effect but his fundamental language and 
socials skills are mostly definitely impacted by his loss and in jeopardy of being 
underdeveloped if he does not receive the proper treatment and intervention.  
 
 As previously mentioned children have a much wider range of coverage for 
hearing benefits than do adults. Medicaid coverage of hearing benefits is an extremely 
complex system in terms of adult coverage because each state sets its own standards and 
there is not requirement within the federal guidelines that mandates each state to cover 
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hearing benefits. Services are mandated, however, for children from birth until age 21. 
The federal government requires that Medicaid cover audiological assessments, hearing 
aid evaluations, and medically necessary hearing aid services, which includes hearing 
aids, hearing accessories, and services (Medicaid Regulations). Although these benefits 
are available the system is not perfect. A study on Medicaid reimbursement of children’s 
hearing services published in the Official Journal of the American Academy of Pediatrics 
found that Medicaid reimbursements are falling short. The study looked at 15 states in 
which Medicaid, Medicare, and private insurance have comparable coverage for hearing 
services and found that Medicaid reimbursement rates have been steadily declining and 
that many states do not even have billing codes for a significant number of hearing 
services need by children. The expansion of newborn hearing screening has added a 
significant number of children to the pool of those who need these services. This study 
raises questions about how well states are meeting federal guidelines because many 
children cannot access the services they need (McManus). 
Medicaid is also required to cover all children for cochlear implants up to age 21. 
Research studies found that cochlear implants can result in net saving of $53,000 per 
child, in stark contrasts to the more than $1 million average expected lifetime cost that 
each child with profound hearing loss prior to language development will likely incur. 
With the operation costing in total about $40,000 these savings are significant (Cochlear 
Implant Frequently Asked Questions).  
 Jamison’s family is too affluent to qualify for Medicaid, so his family relies on 
private insurance coverage. Cochlear implants are in his future within the next two years. 
Most private health insurance companies provide cochlear implant coverage because the 
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implants have been recognized as a standard treatment for severe to profound hearing 
loss due to nerve deafness. It is important to note, however, that repairs and updates for 
cochlear implants are not always covered by insurance (Cochlear Implant Frequently 
Asked Questions). More than 90% of all the commercial health insurance plans in the 
country cover cochlear implants. Managed care plans may be more restrictive about their 
coverage. Additional warranties and insurance on the actual devices themselves can be 
obtained from manufacturers but not private insurance companies (Nussbaum) Over 
40,000 adults and 30,000 children in the United States are cochlear implant recipients, 
however, only 7% of the people in this country who qualify for the implants are hearing 
with this technology today (Hearing Loss Stats).  
 Hearing aids are widely accepted so policy changes on adding coverage will most 
likely face opposition solely from the insurance companies who will have to pay the bills. 
The hearing world may not realize, however, the amount of controversy that cochlear 
implants, specifically, create within the deaf community of this country. In the world of 
those who can hear or gradually lose their hearing, some hearing is considered better than 
non at all. In the deaf world, the sentiment is exactly the opposite; the deaf would rather 
be completely deaf rather than hard of hearing. Deaf children with deaf people do not see 
their circumstances as a tragedy like hearing parents often do. Deaf parents of deaf 
children see their child’s impairment as a blessing of sorts, because it will allow their 
child to grow up fully immersed in deaf culture. The deaf community warns against the 
surgeries potential risks, which include “anesthesia complications, facial nerve damage, 
skin flap necrosis, meningitis, and permanent dizziness” (Gaines). The deaf community 
also points out the variability of success with the devices.  
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 The ethical debate this causes brought both medical and legal biomedical ethics 
considerations to cochlear implant policies. The medical community has verified that 
cochlear implants are the best therapeutic option for people with profound hearing loss. 
By biomedical ethics standards, cochlear implants have also been found to be valid as 
long as implantations are analyzed on a case-by-case basis. This stipulation means that 
ENT (ears, nose, and throat) physicians bear the ethical responsibility to properly assess 
each child as well as provide the child’s parent/guardian with all the material information 
or information pertinent to the procedure and receive formal written consent 
(Ortohinolaryngol).  
 Cochlear implants were first marketed in 1972 and more than 1,000 of the 
primitive models of these devices were implanted between 1972 and the mid 1980’s.The 
FDA formally approved this model of the implant in November of 1984 and several 
hundred children received the devices. By the end of the late 1980’s, most concerns about 
long-term success and the safety of the implants had been resolved. Since then, the 
technology for these implants increases with every passing year. Cochlear implants today 
have much higher performance levels. Acceptance of the implants as assistive devices 
grew rapidly throughout the 90’s and continues to do so today. Implants are increasingly 
recommended by medical professionals and chosen by patients as well. There are two 
major corporations that produce cochlear implants in the United States, which are 
Cochlear Corporation and Advanced Bionics Corporation (History of Cochlear Implants). 
 A study conducted on the effects of having cochlear implants in a world of 
hearing people identified four principle conclusions about the devices’ long-term effects 
for children. First, students with cochlear implants often experience great academic 
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success but may still experience difficulties in a classroom setting. Second, the children 
have strong and healthy relationships with hearing peers rather than hard of hearing 
peers. Third, adolescents’ hearing-deaf identity was heterogeneous and ranged from 
hearing to deaf. Finally, some adolescents with the implants may simultaneously have 
more than one personal identity, which may be expressed at different intensities 
according to their level of functioning and their circumstances (Adelman).  
Time for Change 
 Congress is considering proposed legislation that would make hearing aids and 
hearing healthcare part of the services and benefits covered by the federal Medicare 
program. A Florida Republican, Mark Foley, introduced the bill last fall. Although 
predictions that it will take years for Congress to pass any meaningful legislation on 
hearing benefits may prove to be true, four state legislators have passed laws requiring 
hearing benefits be covered for specific sectors of the population, mostly children, and 
six other states are starting to follow suit. The private sector is also being pushed by 
consumer demand to expand coverage. The hearing industry and manufacturers also 
support an expansion in coverage for obvious reasons. Most campaigns, even before the 
Foley Bill, are targeted at expanding coverage for children. James Potter, the director of 
government relations and public policy at the American Speech-Language-Hearing 
Association, points out that coverage for children is the logical sequel to the nationwide 
campaign for newborn for newborn hearing screening, which made great progress and 
won legislation mandating universal newborn hearing screening. As the baby boomers 
now begin to reach the age for Medicare eligibility, there will be an even larger push 
from that constituency.  
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 The Foley Bill, formally known as H.R. 2934, the Medicare Aural Rehabilitation 
and Hearing Aid Coverage Act of 2001, would add hearing aids to the list of approved 
durable medical devices covered by Medicare. Beneficiaries would then be entitled to 
new hearing aids every three years if needed and patients would be billed personally if 
they exceed their amount of coverage provided by Medicare. Potter sees this bill as well 
intentioned but unlikely to pass, but will still be beneficial for raising awareness. The 
Hearing Industries Association (HIA), which is the trade association for suppliers and 
manufacturers of hearing products, support the Foley Bill but warn that reimbursement 
would have to be high enough to keep manufacturers dedicated to innovation that benefit 
the users of their products. HIA believes that the ability of patients to choose from a 
variety of devices will need to be a significant part of any bill passed (Nemes).  
 Since 2002, bills that would create a federal income tax credit for individuals who 
purchase hearing aids have been repeatedly introduced to Congress. This bill has never 
come up for a vote but constantly gains more and more support over time. The original 
version of the bill, known as the Hearing Aid Assistance Tax Credit or H.R. 1646, 
provides a $500 tax credit per purchased hearing aid to by a hearing impaired person who 
is 55 years of age or older or for a dependent child 18 years or younger. Other family 
members who qualify as dependents for tax purposes are also covered by the act. The 
newest version of the bill requires that a person must have an annual income under 
$200,000 to receive the tax credit. The basic idea of this revision is to bring the total cost 
of the act down by making those who can afford hearing aids pay for them. The bill has a 
wide range of support from organizations such as the Hearing Loss Association of 
America, HIA, ASHA, and the Academy of Doctors of Audiology. Tax credits are an 
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expansion of third-party coverage. The only opposition the bill faces is that the federal 
government would be losing revenue by allowing taxpayers to keep more of their money. 
The Joint Committee on Taxation estimated in 2005 that the bill would cost the federal 
government $300 million in one year and about $1.3 billion over five consecutive years 
(Hearing Aid Assistance Tax Credit). Therefore, cuts would have to be made elsewhere 
in the budget to make up for this benefit. The proposed tax credit would benefit many 
individuals who already have insurance coverage for hearing services. For instance, Blue 
Cross/Blue Shield FEHBP covers up to $1,200 per device despite the fact that on average 
hearing aids cost $1,800 per device. A federal employee who buys a pair of hearing aids 
for $3,500 could use the FEHBP coverage of $1,200 and also receive a $1,000 tax credit. 
Some critics of the bill believe an insurance mandate on hearing benefits would be easier 
because the government would not have to pay the bills (Victorian). 
 The implementation of the ACA holds some major implications for the future of 
the hearing impaired percentage of the population. The enrollment of more individuals in 
health insurance will more likely than not lead to more patients being referred to 
audiologists for hearing-and-balance-related evaluations, which will increase the number 
of people interested in hearing-benefit reform. Also, the actual number of hearing 
impaired will statistically increase and reports will be more accurate. At present, 25 states 
have already taken advantage of the option to expand Medicaid eligibility written into the 
ACA and others may follow suit. The Medicaid eligibility expansion will result in 
expanded hearing aid sales in those states and hearing benefits. As aforementioned, the 
degree of covered care will vary in each state, however, the trend is to follow the 
Massachusetts or “Romneycare” example, which expands hearing benefits. With the 
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aging generation and expansion of hearing benefits audiologists are feeling pressure to 
increase the quality of their services as well as their capacity for service. Competition 
amongst audiologists through high-quality care at lower cost than other professionals in 
the hearing health care field may promote direct access to hearing services (Parker). 
 Other reforms in the hearing services sector of health care would help simplify the 
process and support coverage expansion with public and private insurers alike. One 
element of reform should be increasing the transparency of hearing aid pricing. True 
transparency would mean that practitioners would be expected to unbundle prices and 
make the actual price of the hearing aid obvious separate from any other related charges 
for professional services. Audiologists are often worried about sufficient reimbursement 
for their services and transparency of cost will allow for the negotiation of reasonable 
payment amounts. The development of better benchmarks and objective measurements of 
the benefits of hearing treatment would also help coverage expansion grow. For example, 
John Laftsidis, Alliances Manager of Beltone, believes that the hearing industry should 
conduct a study to show employers how covering hearing benefits will benefit them in 
the long run. Essentially, the main point of the study would be that employers should 
cover hearing costs because employees who can hear better will perform better 
(Victorian). 
 I believe a major reform that should be implemented is the removal of the option 
to waive the medical evaluation before the purchase of hearing aids. Removing the option 
to waive the medical evaluation would ensure that patients receive proper models and 
fittings when they make their purchase. The requirement that patients see a physician 
would also help data collection on this issue and more accurate statistics for the future. 
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The fact that the hearing aid dispenser must inform the consumer that waiving their 
medical evaluation is not in the best interest of his or her health is an indication to me that 
it should not be an option in the first place. In a high stress financial and emotional 
situation, people want to make the process as simple as possible, however, skipping the 
step of seeing a physician prior to being fitted for and purchasing hearing aids is 
counterproductive. 
 The best direction for this country to go in for expanding hearing benefit coverage 
is to remove the option to waive the medical evaluation, pass the Foley Bill, and to make 
hearing part of the new ACA benchmark essential benefits. A hearing aid assistance tax 
credit like the one proposed above would put a large burden on the federal government 
and leave private insurance companies unaccountable. Adding hearing benefits to the 
essential benefits that plans must cover to participate in the insurance market place under 
the ACA would acclimate private insurance to covering hearing benefits, which could be 
easily expanded to all plans from there. Removing the option to waive the medical 
evaluation will instantly increase the quality of services that each individual will receive 
and cut down on wasted expenses, like improperly fitted hearing aids. Expanding hearing 
coverage for adults to the level that children receive it is the next logical step for this 
country. All newborns receive screening for possible hearing impairment, all children 
have access to hearing coverage, now, adults need to be offered that same access.  
As William M. Sage writes, “One person’s malady can harm families, 
workplaces, clubs, churches, and sometimes entire communities” (Sage). The loss of 
hearing is one of this country’s easily fixable maladies, which negatively impacts society, 
yet we chose to ignore it. My father’s hearing affected my entire family and makes his 
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job that much more dangerous. My aunt’s hearing makes teaching special needs 
elementary school students even more of a challenge than it already is and Jamison’s 
entire class of schoolmates is affected by his lack of hearing and subsequent behavior 
issues. Sage goes on to say that “Effective reform must connect individual services to 
population health at as many junctures as possible”(Sage). With increased hearing 
services coverage the overall population of the country will be significantly healthier. 
Mentally and physically, the impacts of hearing loss are all negative and the growing 
number of individuals who will face hearing problems in the near future should be of the 
upmost concern in the medical industry.  
In a time of great change and reform for the health care sector of this country, 
efforts to correct this grievous coverage gap should be in the forefront of reformers’ 
minds. Sage argues that “coordinated investment” is one of the aspects of American 
solidarity in health care. He insists, ”Epidemics and disasters generate widespread 
willingness both to contribute funds and to submit to physical restrictions in order to 
prevent additional physical harm and to keep critical infrastructure functioning” (Sage). I 
would argue that hearing impairments are a pandemic in this country of ghastly 
proportions. The cause of much of the lack of accurate data and actual numbers for 
hearing loss is commoditization of hearing services and devices. Turning patients into 
solely consumers is a dangerous game to play when one of the person’s five senses is at 
stake. Hearing device consumers are often under or uninformed, which leads to the 
purchase of incorrect devices. The option to waive the medical evaluation is even more 
precarious because it takes medical professionals out of the picture completely. Tax 
credits for hearing aids purchasers and greater transparency in price are good first steps to 
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integrating hearing coverage fully into the third-party payer system. However, I believe 
that full coverage of hearing services and devices by both public and private insurance is 
the direction this country should be headed in and is in fact, inevitable with the aging 
baby boomer generation and the vastly increasing number of newborns who will now be 
identified as hearing impaired through mandatory infancy screenings. 
I know first hand how hearing loss impacts a relationship and an entire family. 
My mother’s frustration at having to constantly raise her voice to have a normal 
conversation, my father’s lack of participation in conversations at busy restaurants, and 
rarely getting a response when I’d say “Love you Dad,” as he walked out the door to 
work in the morning, all brought stress into our home. The difference that his hearing 
aids make I his daily life is profound. Unfortunately for the hearing impaired treatment 
comes with a very high price. My father was fortunate enough to be able to pay this price, 
no matter how much anxiety the costly purchase caused him. The day after my father 
purchased his hearing aids he walked out the door to work and when I called, “Love you 
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